Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease

References

• CalverleyPMCOPD: what is the unmet need?Br J Pharmacol2008155448749318794891
   PubMed Web of Science ®Google Scholar
• YawnBPColiceGLHodderRPractical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care settingInt J Chron Obstruct Pulmon Dis2012749550222888221
   PubMed Web of Science ®Google Scholar
• RestrepoRDAlvarezMTWittnebelLDMedication adherence issues in patients treated for COPDInt J Chron Obstruct Pulmon Dis20083337138418990964
   PubMedGoogle Scholar
• GeorgeJKongDCThomanRStewartKFactors associated with medication nonadherence in patients with COPDChest200512853198320416304262
   PubMed Web of Science ®Google Scholar
• BourbeauJBartlettSJPatient adherence in COPDThorax200863983183818728206
   PubMed Web of Science ®Google Scholar
• DecramerMJanssensWMiravitllesMChronic obstructive pulmonary diseaseLancet201237998231341135122314182
   PubMed Web of Science ®Google Scholar
• BiswasSHwangJWKirkhamPARahmanIPharmacological and dietary antioxidant therapies for chronic obstructive pulmonary diseaseCurr Med Chem201320121496153022963552
   PubMed Web of Science ®Google Scholar
• BarnesPJCorticosteroid resistance in patients with asthma and chronic obstructive pulmonary diseaseJ Allergy Clin Immunol2013131363664523360759
   PubMed Web of Science ®Google Scholar
• MarwickJAChungKFGlucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2010529730920856829
   PubMedGoogle Scholar
• GeorgeJIoannides-DemosLLSantamariaNMKongDCStewartKUse of complementary and alternative medicines by patients with chronic obstructive pulmonary diseaseMed J Aust2004181524825115347271
   PubMed Web of Science ®Google Scholar
• SharafkhanehAVelamuriSBadmaevVLanCHananiaNThe potential role of natural agents in treatment of airway inflammationTher Adv Respir Dis20071210512019124352
   PubMedGoogle Scholar
• GuoRPittlerMHErnstEHerbal medicines for the treatment of COPD: a systematic reviewEur Respir J200628233033816880367
   PubMed Web of Science ®Google Scholar
• AnandPKunnumakkaraABHarikumarKBAhnKSBadmaevVAggarwalBBModification of cysteine residue in p65 subunit of nuclear factor-kappaB (NF-kappaB) by picroliv suppresses NF-kappaB-regulated gene products and potentiates apoptosisCancer Res200868218861887018974130
   PubMed Web of Science ®Google Scholar
• DorschWStuppnerHWagnerHGroppMDemoulinSRingJAntiasthmatic effects of Picrorhiza kurroa: androsin prevents allergen-and PAF-induced bronchial obstruction in guinea pigsInt Arch Allergy Appl Immunol1991952–31281331718906
   PubMedGoogle Scholar
• SutcliffeAHollinsFGomezEIncreased nicotinamide adenine dinucleotide phosphate oxidase 4 expression mediates intrinsic airway smooth muscle hypercontractility in asthmaAm J Respir Crit Care Med2012185326727422108207
   PubMed Web of Science ®Google Scholar
• StefanskaJSarniakAWlodarczykAApocynin reduces reactive oxygen species concentrations in exhaled breath condensate in asthmaticsExp Lung Res2012382909922296407
   PubMed Web of Science ®Google Scholar
• LiGHLeiXXYiYMXuBLWangHPDuJStudies on the effect of Ginkgo biloba extracts on NF-kappaB pathwayZhong Yao Cai200831913571360 Chinese19180958
   PubMedGoogle Scholar
• RogerioAPSá-NunesAFaccioliLHThe activity of medicinal plants and secondary metabolites on eosinophilic inflammationPharmacol Res201062429830720450976
   PubMed Web of Science ®Google Scholar
• TangYXuYXiongSThe effect of Ginkgo Biloba extract on the expression of PKCalpha in the inflammatory cells and the level of IL-5 in induced sputum of asthmatic patientsJ Huazhong Univ Sci Technolog Med Sci200727437538017828490
   PubMedGoogle Scholar
• ThomasMSheranJSmithNFonsecaSLeeAJAKL1, a botanical mixture for the treatment of asthma: a randomised, double-blind, placebo-controlled, cross-over studyBMC Pulm Med20077417374147
   PubMedGoogle Scholar
• Medicines and Healthcare Products Regulatory Agency, UK Department of HealthGood Manufacturing Practice Available from: http://www.mhra.gov.uk/Howweregulate/Medicines/Inspectionandstandards/GoodManufacturingPractice/index.htmAccessed April 1, 2014
   Google Scholar
• Global Strategy for the Diagnosis, Management, and Prevention of COPDGlobal Initiative for Chronic Obstructive Pulmonary Disease (GOLD) [updated 2014]. Available from: http://www.goldcopd.org/Accessed April 8, 2014
   Google Scholar
• University of East AngliaTreatment With AKL1 in Obstructive Airways Disease (The TAKL Study) Available from: http://clinicaltrials.gov/ct2/show/NCT0920127. NLM identifier: NCT0920127Accessed April 8, 2014
   Google Scholar
• BirringSSPrudonBCarrAJSinghSJMorganMDPavordIDDevelopment of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)Thorax200358433934312668799
   PubMed Web of Science ®Google Scholar
• RajAAPavordDIBirringSSClinical cough IV: what is the minimal important difference for the Leicester Cough Questionnaire?Handb Exp Pharmacol200918731132018825348
   PubMedGoogle Scholar
• JonesPWQuirkFHBaveystockCMLittlejohnsPA self-complete measure of health status for chronic airflow limitation. The St George’s Respiratory QuestionnaireAm Rev Respir Dis19921456132113271595997
   PubMed Web of Science ®Google Scholar
• JonesPWSt George’s Respiratory Questionnaire: MCIDCOPD200521757917136966
   PubMedGoogle Scholar
• KocksJWTuinengaMGUilSMvan den BergJWStahlEvan der MolenTHealth status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaireRespir Res200676216603063
   PubMed Web of Science ®Google Scholar
• van der MolenTWillemseBWSchokkerSten HackenNHPostmaDSJuniperEFDevelopment, validity and responsiveness of the Clinical COPD QuestionnaireHealth Qual Life Outcomes200311312773199
   PubMedGoogle Scholar
• Clinical COPD Questionnaire Available from: http://www.ccq.nl/Accessed July 25, 2013
   Google Scholar
• JonesPWPriceDvan der MolenTRole of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2011628929621697993
   PubMed Web of Science ®Google Scholar
• FletcherCMElmesPCFairbairnASWoodCHThe significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working populationBr Med J19592514725726613823475
   PubMed Web of Science ®Google Scholar
• StentonCThe MRC breathlessness scaleOccup Med (Lond)200858322622718441368
   PubMed Web of Science ®Google Scholar
• BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
   PubMed Web of Science ®Google Scholar
• CoteCGCasanovaCMarínJMValidation and comparison of reference equations for the 6-min walk distance testEur Respir J200831357157817989117
   PubMed Web of Science ®Google Scholar
• CoteCGPinto-PlataVKasprzykKDordellyLJCelliBRThe 6-min walk distance, peak oxygen uptake, and mortality in COPDChest200713261778178517925409
   PubMed Web of Science ®Google Scholar
• [No author listed]Standardization of Spirometry, 1994 Update. American Thoracic SocietyAm J Respir Crit Care Med19951523110711367663792
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• AnXZhangALMayBHLinLXuYXueCCOral Chinese herbal medicine for improvement of quality of life in patients with stable chronic obstructive pulmonary disease: a systematic reviewJ Altern Complement Med201218873174322803654
   PubMed Web of Science ®Google Scholar
• SorknessRLCAM and respiratory diseaseNutr Clin Pract200924560961519841248
   PubMed Web of Science ®Google Scholar